Evidence map›Paper›PMID 36853189›Full record

ArticleNanomedicine (London, England)2022

Inhibition of human APE1 and MTH1 DNA repair proteins by dextran-coated γ-Fe

Erdem Coskun, Neenu Singh, Leona D Scanlan, Pawel Jaruga, Shareen H Doak, Miral Dizdaroglu, Bryant C Nelson

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Erdem CoskunInstitute for Bioscience & Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.ORCID 0000-0002-9927-4188
Neenu SinghLeicester School of Allied Health Sciences, Faculty of Health & Life Sciences, De Montfort University, The Gateway, Leicester, LE1 9BH, UK.ORCID 0000-0001-7620-9984
Leona D ScanlanCalifornia Environmental Protection Agency, Office of Environmental Health Hazard Assessment, 1001 I Street, Sacramento, CA 95814, USA.ORCID 0000-0002-1076-8764
Pawel JarugaBiomolecular Measurement Division, National Institute of Standards & Technology, Gaithersburg, MD 20899, USA.ORCID 0000-0001-9192-6084
Shareen H DoakInstitute of Life Science, Center for NanoHealth, Swansea University Medical School, Wales, SA2 8PP, UK.ORCID 0000-0002-6753-1987
Miral DizdarogluBiomolecular Measurement Division, National Institute of Standards & Technology, Gaithersburg, MD 20899, USA.ORCID 0000-0003-0283-1695
Bryant C NelsonBiosystems & Biomaterials Division, National Institute of Standards & Technology, Gaithersburg, MD 20899, USA.ORCID 0000-0001-8166-4121
Material Measurement Laboratory · USAdvanced Bioscience Laboratories (United States) · USCalifornia Environmental Protection Agency · USDe Montfort University · GBNational Institute of Standards and Technology · USSwansea University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DextransMagnetic Iron Oxide NanoparticlesDNA RepairHumansDextransanticancer agentsAPE1DNA repair protein inhibitioniron oxide nanoparticlesMTH1

Identifiers

PMID36853189
PMCPMC10031551
OpenAlexW4322616739

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.